These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34040698)

  • 1. Biomarkers for hepatocellular carcinoma based on body fluids and feces.
    Guan MC; Ouyang W; Wang MD; Liang L; Li N; Fu TT; Shen F; Lau WY; Xu QR; Huang DS; Zhu H; Yang T
    World J Gastrointest Oncol; 2021 May; 13(5):351-365. PubMed ID: 34040698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota.
    Nath LR; Murali M; Nair B
    World J Gastrointest Oncol; 2021 Dec; 13(12):2219-2222. PubMed ID: 35070054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
    Pelizzaro F; Cardin R; Penzo B; Pinto E; Vitale A; Cillo U; Russo FP; Farinati F
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress of gut microbiota in hepatocellular carcinoma.
    Li K; Liu J; Qin X
    J Clin Lab Anal; 2022 Jul; 36(7):e24512. PubMed ID: 35719048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside.
    Guan MC; Wang MD; Liu SY; Ouyang W; Liang L; Pawlik TM; Xu QR; Huang DS; Shen F; Zhu H; Yang T
    World J Gastrointest Oncol; 2021 Apr; 13(4):197-215. PubMed ID: 33889272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of cell free DNA in the diagnosis of HCC.
    Banini BA; Sanyal AJ
    Hepatoma Res; 2019; 5():. PubMed ID: 31673629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies.
    Kang Y; Cai Y; Yang Y
    Liver Cancer; 2022 Apr; 11(2):113-125. PubMed ID: 35634424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma.
    Li L; Diao W; Zen K
    J Hepatocell Carcinoma; 2014; 1():21-33. PubMed ID: 27508173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
    Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
    Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
    Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
    Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma.
    Choi EJ; Kim YJ
    J Liver Cancer; 2022 Sep; 22(2):103-114. PubMed ID: 37383403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.
    Rao BC; Lou JM; Wang WJ; Li A; Cui GY; Yu ZJ; Ren ZG
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):109-115. PubMed ID: 32037278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
    Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
    Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
    Bao H; Su H
    Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor DNA in hepatocellular carcinoma: trends and challenges.
    Tang JC; Feng YL; Guo T; Xie AY; Cai XJ
    Cell Biosci; 2016; 6():32. PubMed ID: 27182434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma.
    Umeda S; Kanda M; Kodera Y
    Expert Rev Mol Diagn; 2019 Aug; 19(8):725-738. PubMed ID: 31248309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.